Benitec Biopharma

BNTC

Market cap $406M

11.98 USD

-0.98

7.56%

At close Updated Dec 12, 4:00 PM EST

Pre-market

After hours

12.21

+0.23

1.92%

1 day

-7.56%

5 days

-12.04%

1 month

-10.86%

3 months

-13.5%

6 months

-24.75%

Year to date

-0.83%

1 year

-3%

5 years

-74.09%

10 years

-98.97%

About: Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Employees: 19

Healthcare Biotechnology